Exendin-4 promotes GSIS without increasing β-cell number through upregulation of glucose-sensing apparatus and mitochondrial oxidative phosphorylation machinery genes in hPSC-derived β-cells

<p><strong>Poster by Abdoulaye Diane, Razik Bin Abdul Mu-u-min, Asma Allouch, and Heba H. Al-Siddiqi (Hamad Bin Khalifa University)</strong></p> <p>Background: Impaired insulin secretion contributes to the pathogenesis of diabetes mellitus type 1 (T1DM) through autoimmu...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Abdoulaye Diane (14152749) (author)
مؤلفون آخرون: Razik Bin Abdul Mu-u-min (15430008) (author), Asma Allouch (15430010) (author), Heba H Al-Siddiqi (12204889) (author)
منشور في: 2023
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513564697427968
author Abdoulaye Diane (14152749)
author2 Razik Bin Abdul Mu-u-min (15430008)
Asma Allouch (15430010)
Heba H Al-Siddiqi (12204889)
author2_role author
author
author
author_facet Abdoulaye Diane (14152749)
Razik Bin Abdul Mu-u-min (15430008)
Asma Allouch (15430010)
Heba H Al-Siddiqi (12204889)
author_role author
dc.creator.none.fl_str_mv Abdoulaye Diane (14152749)
Razik Bin Abdul Mu-u-min (15430008)
Asma Allouch (15430010)
Heba H Al-Siddiqi (12204889)
dc.date.none.fl_str_mv 2023-05-17T11:39:29Z
dc.identifier.none.fl_str_mv 10.57945/manara.22785233.v1
dc.relation.none.fl_str_mv https://figshare.com/articles/poster/Exendin-4_promotes_GSIS_without_increasing_-cell_number_through_upregulation_of_glucose-sensing_apparatus_and_mitochondrial_oxidative_phosphorylation_machinery_genes_in_hPSC-derived_-cells/22785233
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Medical biotechnology
Diabetes
Exendin-4
Mitochondria
hPSC-derived β-cells
Differentiation
dc.title.none.fl_str_mv Exendin-4 promotes GSIS without increasing β-cell number through upregulation of glucose-sensing apparatus and mitochondrial oxidative phosphorylation machinery genes in hPSC-derived β-cells
dc.type.none.fl_str_mv Image
Poster
info:eu-repo/semantics/publishedVersion
image
description <p><strong>Poster by Abdoulaye Diane, Razik Bin Abdul Mu-u-min, Asma Allouch, and Heba H. Al-Siddiqi (Hamad Bin Khalifa University)</strong></p> <p>Background: Impaired insulin secretion contributes to the pathogenesis of diabetes mellitus type 1 (T1DM) through autoimmune destruction of pancreatic β-cells and the pathogenesis of diabetes mellitus type 2 (T2DM) through β-cell dedifferentiation and other mechanisms. Emerging β-cell replacement with human pluripotent stem cell (hPSC)–derived β-cells may provide remedial cell therapy. Most in vitro differentiation protocols have generated hPSC-derived β-cells with either immature phenotype such as impaired or weakened glucose-stimulated insulin secretion (GSIS) relative to primary β-cells. Evidence has shown that β-cell mitochondria play a central role in coupling glucose metabolism to insulin exocytosis. Therefore, the impairment of GSIS in hPSC-derived β-cells may be attributed to impaired glucose sensing and/or mitochondrial dysfunction. </p> <p>Objective: The aim of this study is to investigate the effect of Exendin-4 (GLP-1 receptor analog), known to promote mitochondrial function, on enhancing maturation and functionality of hPSC-derived β-cells.</p> <p>Methods: Differentiation of hPSC into β-cells was carried out in a stepwise 3D differentiation protocol using 30 ml spinner flask adapted from the protocol of Veres et al. (2019). This consists of 6 stages: S1, definitive endoderm; S2, gut tube endoderm; S3, pancreatic progenitors 1; S4, pancreatic progenitors 2; S5, endocrine precursors; and S6, β-like cells. To determine the differentiation efficiency, relevant stage-specific marker expression was assessed at each stage using flow cytometry. Finally, to further test the effect of GLP-1 receptor analog on the functionality of hPSC-derived β-cells, 50 nM exendin-4 was added to the suspension culture during the last three days of differentiation and GSIS was performed. Gene expression in cell clusters was determined by RT-PCR. Data are mean ± SEM (n=6)</p> <p>Results: Flow cytometry data for relevant stage-specific markers showed 96 % OCT4 positive, 89% SOX17 and 83% PDX1 positive cells, indicating good pluripotency, high definite endoderm and pancreatic progenitor induction, respectively.  As for β-cell markers, we found 41.4% NKX6.1/insulin double positive cells at final stage 6, indicating a generation of β-cells. Expression profiling during differentiation confirmed the generation of insulin-expressing β-cells. However, GSIS data showed no difference in c-peptide secretion between low (2.8mM) and high (20 mM) glucose but high response to direct cellular depolarization-mediated c-peptide by KCl; suggesting a lack of functional β-cells. Interestingly, addition of Exendin-4 (50 nM) during the last 3 days of the differentiation significantly enhanced GSIS associated with increased expression of glucose-sensing apparatus genes (Glut2, G6P2C, GCK) and genes encoding mitochondrial oxidative phosphorylation machinery.</p> <p>Conclusion: Our data demonstrated for the first time in 3D differentiation of hPSC-derived β-cells that addition of Exendin-4 promotes GSIS through upregulation of both glucose-sensing apparatus and mitochondrial oxidative phosphorylation machinery genes without increasing β-cell number.</p>
eu_rights_str_mv openAccess
id Manara2_27ef46b5b674b7860c50926e98dcf78f
identifier_str_mv 10.57945/manara.22785233.v1
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/22785233
publishDate 2023
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Exendin-4 promotes GSIS without increasing β-cell number through upregulation of glucose-sensing apparatus and mitochondrial oxidative phosphorylation machinery genes in hPSC-derived β-cellsAbdoulaye Diane (14152749)Razik Bin Abdul Mu-u-min (15430008)Asma Allouch (15430010)Heba H Al-Siddiqi (12204889)Biomedical and clinical sciencesMedical biotechnologyDiabetesExendin-4MitochondriahPSC-derived β-cellsDifferentiation<p><strong>Poster by Abdoulaye Diane, Razik Bin Abdul Mu-u-min, Asma Allouch, and Heba H. Al-Siddiqi (Hamad Bin Khalifa University)</strong></p> <p>Background: Impaired insulin secretion contributes to the pathogenesis of diabetes mellitus type 1 (T1DM) through autoimmune destruction of pancreatic β-cells and the pathogenesis of diabetes mellitus type 2 (T2DM) through β-cell dedifferentiation and other mechanisms. Emerging β-cell replacement with human pluripotent stem cell (hPSC)–derived β-cells may provide remedial cell therapy. Most in vitro differentiation protocols have generated hPSC-derived β-cells with either immature phenotype such as impaired or weakened glucose-stimulated insulin secretion (GSIS) relative to primary β-cells. Evidence has shown that β-cell mitochondria play a central role in coupling glucose metabolism to insulin exocytosis. Therefore, the impairment of GSIS in hPSC-derived β-cells may be attributed to impaired glucose sensing and/or mitochondrial dysfunction. </p> <p>Objective: The aim of this study is to investigate the effect of Exendin-4 (GLP-1 receptor analog), known to promote mitochondrial function, on enhancing maturation and functionality of hPSC-derived β-cells.</p> <p>Methods: Differentiation of hPSC into β-cells was carried out in a stepwise 3D differentiation protocol using 30 ml spinner flask adapted from the protocol of Veres et al. (2019). This consists of 6 stages: S1, definitive endoderm; S2, gut tube endoderm; S3, pancreatic progenitors 1; S4, pancreatic progenitors 2; S5, endocrine precursors; and S6, β-like cells. To determine the differentiation efficiency, relevant stage-specific marker expression was assessed at each stage using flow cytometry. Finally, to further test the effect of GLP-1 receptor analog on the functionality of hPSC-derived β-cells, 50 nM exendin-4 was added to the suspension culture during the last three days of differentiation and GSIS was performed. Gene expression in cell clusters was determined by RT-PCR. Data are mean ± SEM (n=6)</p> <p>Results: Flow cytometry data for relevant stage-specific markers showed 96 % OCT4 positive, 89% SOX17 and 83% PDX1 positive cells, indicating good pluripotency, high definite endoderm and pancreatic progenitor induction, respectively.  As for β-cell markers, we found 41.4% NKX6.1/insulin double positive cells at final stage 6, indicating a generation of β-cells. Expression profiling during differentiation confirmed the generation of insulin-expressing β-cells. However, GSIS data showed no difference in c-peptide secretion between low (2.8mM) and high (20 mM) glucose but high response to direct cellular depolarization-mediated c-peptide by KCl; suggesting a lack of functional β-cells. Interestingly, addition of Exendin-4 (50 nM) during the last 3 days of the differentiation significantly enhanced GSIS associated with increased expression of glucose-sensing apparatus genes (Glut2, G6P2C, GCK) and genes encoding mitochondrial oxidative phosphorylation machinery.</p> <p>Conclusion: Our data demonstrated for the first time in 3D differentiation of hPSC-derived β-cells that addition of Exendin-4 promotes GSIS through upregulation of both glucose-sensing apparatus and mitochondrial oxidative phosphorylation machinery genes without increasing β-cell number.</p>2023-05-17T11:39:29ZImagePosterinfo:eu-repo/semantics/publishedVersionimage10.57945/manara.22785233.v1https://figshare.com/articles/poster/Exendin-4_promotes_GSIS_without_increasing_-cell_number_through_upregulation_of_glucose-sensing_apparatus_and_mitochondrial_oxidative_phosphorylation_machinery_genes_in_hPSC-derived_-cells/22785233CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/227852332023-05-17T11:39:29Z
spellingShingle Exendin-4 promotes GSIS without increasing β-cell number through upregulation of glucose-sensing apparatus and mitochondrial oxidative phosphorylation machinery genes in hPSC-derived β-cells
Abdoulaye Diane (14152749)
Biomedical and clinical sciences
Medical biotechnology
Diabetes
Exendin-4
Mitochondria
hPSC-derived β-cells
Differentiation
status_str publishedVersion
title Exendin-4 promotes GSIS without increasing β-cell number through upregulation of glucose-sensing apparatus and mitochondrial oxidative phosphorylation machinery genes in hPSC-derived β-cells
title_full Exendin-4 promotes GSIS without increasing β-cell number through upregulation of glucose-sensing apparatus and mitochondrial oxidative phosphorylation machinery genes in hPSC-derived β-cells
title_fullStr Exendin-4 promotes GSIS without increasing β-cell number through upregulation of glucose-sensing apparatus and mitochondrial oxidative phosphorylation machinery genes in hPSC-derived β-cells
title_full_unstemmed Exendin-4 promotes GSIS without increasing β-cell number through upregulation of glucose-sensing apparatus and mitochondrial oxidative phosphorylation machinery genes in hPSC-derived β-cells
title_short Exendin-4 promotes GSIS without increasing β-cell number through upregulation of glucose-sensing apparatus and mitochondrial oxidative phosphorylation machinery genes in hPSC-derived β-cells
title_sort Exendin-4 promotes GSIS without increasing β-cell number through upregulation of glucose-sensing apparatus and mitochondrial oxidative phosphorylation machinery genes in hPSC-derived β-cells
topic Biomedical and clinical sciences
Medical biotechnology
Diabetes
Exendin-4
Mitochondria
hPSC-derived β-cells
Differentiation